RBPWorld - a comprehensive database of RNA Binding Proteins

Welcome to

RBP World!

Drugs target to PARP2

Drug name	Drug type	Disease/phenotype	Mechanism of action(MoA)	Phase	Status	Source
PAMIPARIB	Small molecule	none	Poly [ADP-ribose] polymerase 2 inhibitor	3	['Recruiting', 'Completed', 'Active, not recruiting', 'Recruiting', '-', 'Terminated', 'Recruiting', 'Recruiting', 'Active, not recruiting', 'Active, not recruiting', 'Completed', 'Active, not recruiting', 'Not yet recruiting', 'Recruiting', 'Not yet recruiting', 'Enrolling by invitation', 'Recruiting', 'Active, not recruiting', 'Recruiting', 'Not yet recruiting', 'Recruiting', 'Recruiting', 'Withdrawn', 'Completed', 'Active, not recruiting']	['ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ATC', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials']
NIRAPARIB	Small molecule	none	Poly [ADP-ribose] polymerase 2 inhibitor	4	['Recruiting', '-', 'Recruiting', 'Completed', 'Withdrawn', 'Terminated', 'Recruiting', 'Completed', 'Completed', 'Terminated', 'Recruiting', 'Terminated', 'Active, not recruiting', 'Not yet recruiting', 'Recruiting', 'Recruiting', 'Recruiting', 'Active, not recruiting', 'Active, not recruiting', 'Recruiting', 'Terminated', 'Completed', 'Active, not recruiting', 'Recruiting', 'Not yet recruiting', 'Completed', 'Recruiting', 'Recruiting', 'Terminated', 'Completed', 'Recruiting', 'Completed', 'Not yet recruiting', 'Completed', 'Not yet recruiting', 'Unknown status', 'Terminated', 'Recruiting', 'Recruiting', 'Completed', 'Terminated', 'Recruiting', 'Not yet recruiting', 'Withdrawn', 'Recruiting', 'Recruiting', 'Terminated', 'Withdrawn', 'Recruiting', 'Active, not recruiting', 'Recruiting', 'Active, not recruiting', 'Not yet recruiting', '-', 'Recruiting', 'Not yet recruiting', 'Active, not recruiting', 'Completed', 'Recruiting', '-', 'Active, not recruiting', 'Recruiting', 'Active, not recruiting', 'Recruiting', 'Recruiting', 'Recruiting', 'Recruiting', 'Recruiting', 'Recruiting', 'Active, not recruiting', 'Recruiting', 'Recruiting', 'Recruiting', 'Completed', 'Not yet recruiting', 'Not yet recruiting', 'Recruiting', 'Active, not recruiting', 'Recruiting', 'Recruiting', 'Recruiting', 'Recruiting', 'Recruiting', 'Active, not recruiting', 'Terminated', 'Not yet recruiting', '-', 'Active, not recruiting', 'Recruiting', 'Recruiting', 'Terminated', 'Recruiting', 'Active, not recruiting', 'Recruiting', 'Completed', 'Completed', 'Recruiting', 'Recruiting', 'Not yet recruiting', 'Recruiting', 'Recruiting', 'Completed', 'Active, not recruiting']	['ClinicalTrials', 'ATC', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'FDA', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'FDA', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'FDA', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials']
OLAPARIB	Small molecule	none	PARP 1, 2 and 3 inhibitor	4	['Unknown status', 'Active, not recruiting', 'Recruiting', 'Active, not recruiting', 'Recruiting', 'Active, not recruiting', 'Active, not recruiting', 'Not yet recruiting', 'Active, not recruiting', 'Completed', 'Recruiting', 'Recruiting', 'Active, not recruiting', 'Completed', 'Recruiting', 'Recruiting', 'Active, not recruiting', 'Recruiting', 'Recruiting', 'Active, not recruiting', 'Recruiting', 'Recruiting', 'Recruiting', 'Not yet recruiting', 'Recruiting', 'Completed', 'Active, not recruiting', 'Completed', 'Recruiting', 'Completed', 'Completed', 'Active, not recruiting', 'Enrolling by invitation', 'Active, not recruiting', 'Unknown status', 'Recruiting', 'Active, not recruiting', 'Active, not recruiting', 'Not yet recruiting', 'Completed', 'Not yet recruiting', 'Completed', 'Enrolling by invitation', 'Active, not recruiting', 'Completed', 'Recruiting', 'Recruiting', 'Completed', 'Terminated', 'Active, not recruiting', 'Unknown status', 'Terminated', 'Active, not recruiting', 'Recruiting', 'Completed', 'Active, not recruiting', 'Active, not recruiting', 'Unknown status', 'Not yet recruiting', 'Unknown status', 'Recruiting', 'Unknown status', 'Recruiting', 'Recruiting', 'Active, not recruiting', 'Recruiting', 'Recruiting', 'Recruiting', 'Recruiting', 'Recruiting', 'Active, not recruiting', 'Recruiting', 'Recruiting', 'Recruiting', 'Withdrawn', 'Recruiting', 'Recruiting', 'Active, not recruiting', 'Completed', 'Active, not recruiting', 'Active, not recruiting', 'Completed', 'Active, not recruiting', 'Active, not recruiting', 'Active, not recruiting', 'Completed', 'Recruiting', 'Recruiting', 'Recruiting', 'Recruiting', 'Completed', 'Withdrawn', 'Recruiting', 'Terminated', 'Active, not recruiting', 'Completed', 'Enrolling by invitation', 'Recruiting', 'Completed', 'Active, not recruiting', 'Suspended', 'Completed', 'Completed', '-', 'Recruiting', 'Not yet recruiting', 'Recruiting', '-', 'Recruiting', 'Active, not recruiting', 'Active, not recruiting', 'Recruiting', 'Unknown status', 'Recruiting', 'Recruiting', 'Terminated', 'Recruiting', 'Recruiting', 'Completed', 'Completed', 'Active, not recruiting', 'Terminated', 'Recruiting', 'Completed', 'Recruiting', 'Recruiting', 'Completed', 'Active, not recruiting', 'Active, not recruiting', 'Active, not recruiting', 'Recruiting', 'Recruiting', 'Terminated', 'Completed', 'Active, not recruiting', 'Completed', 'Recruiting', 'Recruiting', 'Recruiting', 'Withdrawn', 'Active, not recruiting', 'Withdrawn', 'Completed', 'Active, not recruiting', 'Completed', 'Recruiting', 'Recruiting', 'Active, not recruiting', 'Recruiting', 'Recruiting', 'Recruiting', 'Completed', 'Recruiting', 'Recruiting', 'Not yet recruiting', 'Recruiting', 'Active, not recruiting', 'Terminated', '-', 'Recruiting', 'Active, not recruiting', 'Recruiting', 'Completed', 'Recruiting', 'Recruiting', 'Recruiting', 'Active, not recruiting', 'Active, not recruiting', 'Recruiting', 'Withdrawn', 'Unknown status', 'Active, not recruiting', 'Completed', 'Not yet recruiting', 'Recruiting', 'Completed', 'Recruiting', 'Unknown status', 'Not yet recruiting', 'Recruiting', 'Recruiting', 'Not yet recruiting', 'Recruiting', 'Recruiting', 'Unknown status', 'Recruiting', 'Active, not recruiting', 'Withdrawn', 'Recruiting', 'Terminated', 'Recruiting', 'Recruiting', 'Recruiting', 'Active, not recruiting', 'Completed', 'Not yet recruiting', 'Completed', 'Active, not recruiting', 'Active, not recruiting', 'Withdrawn']	['ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'DailyMed', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'DailyMed', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ATC', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials']
TALAZOPARIB	Small molecule	none	Poly [ADP-ribose] polymerase 2 inhibitor	4	['Completed', 'Recruiting', 'Completed', 'Withdrawn', 'Terminated', 'Completed', 'Terminated', 'Recruiting', 'Active, not recruiting', 'Recruiting', 'Completed', '-', 'Recruiting', 'Active, not recruiting', 'Active, not recruiting', 'Active, not recruiting', 'Completed', 'Withdrawn', 'Completed', 'Recruiting', 'Recruiting', 'Not yet recruiting', 'Active, not recruiting', 'Completed', '-', '-', 'Completed', 'Withdrawn', 'Recruiting', 'Recruiting', 'Completed', 'Recruiting', 'Terminated', 'Completed', 'Recruiting', 'Recruiting', 'Recruiting', 'Recruiting', 'Completed', 'Completed', 'Not yet recruiting', 'Completed', 'Not yet recruiting', 'Recruiting', 'Recruiting', 'Active, not recruiting', 'Recruiting', 'Terminated', 'Recruiting', 'Recruiting', 'Recruiting', 'Completed', 'Active, not recruiting', 'Active, not recruiting', 'Terminated', 'Not yet recruiting', 'Active, not recruiting', 'Recruiting', 'Recruiting', 'Completed', 'Recruiting', 'Active, not recruiting', 'Recruiting', 'Recruiting', 'Completed', 'Recruiting', 'Recruiting', 'Not yet recruiting', 'Completed', 'Active, not recruiting', 'Recruiting', 'Active, not recruiting']	['ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'FDA', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ATC', 'FDA', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials']
VELIPARIB	Small molecule	none	PARP 1, 2 and 3 inhibitor	3	['Active, not recruiting', 'Completed', 'Completed', 'Completed', 'Active, not recruiting', 'Suspended', 'Completed', 'Active, not recruiting', 'Unknown status', 'Completed', 'Completed', 'Completed', 'Completed', 'Unknown status', 'Active, not recruiting', 'Recruiting', 'Active, not recruiting', 'Active, not recruiting', 'Completed', 'Completed', 'Completed', 'Completed', 'Completed', 'Completed', 'Completed', 'Completed', 'Completed', 'Completed', '-', 'Recruiting', 'Completed', 'Completed', 'Completed', 'Active, not recruiting', 'Withdrawn', 'Withdrawn', 'Withdrawn', 'Recruiting', 'Completed', 'Active, not recruiting', 'Completed', 'Completed', 'Completed', 'Completed', 'Unknown status', 'Withdrawn', 'Completed', 'Completed', 'Completed', 'Active, not recruiting', 'Completed', 'Completed', 'Active, not recruiting', 'Active, not recruiting', 'Completed', 'Completed', 'Completed', 'Completed', 'Completed', 'Completed', 'Active, not recruiting', 'Completed', 'Completed', 'Completed', 'Completed', 'Terminated', 'Completed', 'Active, not recruiting', 'Terminated', 'Active, not recruiting', 'Recruiting', 'Completed', 'Completed']	['ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ATC', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials']
RUCAPARIB	Small molecule	none	PARP 1, 2 and 3 inhibitor	4	['Terminated', '-', 'Recruiting', 'Recruiting', 'Active, not recruiting', 'Active, not recruiting', 'Recruiting', 'Recruiting', 'Completed', 'Active, not recruiting', 'Active, not recruiting', 'Active, not recruiting', 'Completed', 'Active, not recruiting', '-', 'Active, not recruiting', 'Recruiting', 'Completed', 'Active, not recruiting', 'Recruiting', 'Withdrawn', 'Recruiting', 'Recruiting', 'Completed', 'Terminated', 'Recruiting', 'Active, not recruiting', 'Recruiting', 'Completed', 'Active, not recruiting', 'Recruiting', 'Active, not recruiting', 'Active, not recruiting', 'Recruiting', 'Completed', 'Completed', 'Active, not recruiting', 'Recruiting', 'Completed', 'Active, not recruiting', '-', 'Completed', 'Completed', 'Completed', 'Recruiting']	['ClinicalTrials', 'ATC', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'FDA', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'DailyMed', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials']
SENAPARIB	Small molecule	none	Poly [ADP-ribose] polymerase 2 inhibitor	2	['Recruiting', 'Completed', 'Not yet recruiting', 'Completed', 'Withdrawn', 'Completed', 'Completed', 'Completed', 'Recruiting']	['ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials']
TALAZOPARIB TOSYLATE	Small molecule	none	Poly [ADP-ribose] polymerase 2 inhibitor	4	['-', 'Recruiting', 'Not yet recruiting', 'Active, not recruiting', 'Recruiting', 'Active, not recruiting', '-']	['FDA', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'FDA']
RUCAPARIB CAMSYLATE	Small molecule	none	PARP 1, 2 and 3 inhibitor	4	['Completed', '-', 'Recruiting', '-']	['ClinicalTrials', 'FDA', 'ClinicalTrials', 'DailyMed']
E-7016	Small molecule	none	PARP 1, 2 and 3 inhibitor	2	['Completed', 'Terminated']	['ClinicalTrials', 'ClinicalTrials']
NIRAPARIB TOSYLATE	Small molecule	none	Poly [ADP-ribose] polymerase 2 inhibitor	4	['-', '-', 'Recruiting', '-', 'Not yet recruiting']	['FDA', 'FDA', 'ClinicalTrials', 'FDA', 'ClinicalTrials']
2X-121	Small molecule	none	Poly [ADP-ribose] polymerase 2 inhibitor	2	['Active, not recruiting', 'Withdrawn', 'Recruiting', 'Recruiting']	['ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials']